Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Guardant Health
ISIN US40131M1099
|WKN A2N5RY
Market cap (in EUR)
19,635 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 19,635 m |
| EPS, EUR | -3.00 |
| P/B ratio | 57.4 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 870 m |
| Net income, EUR | -369 m |
| Profit margin | -42.39% |
What ETF is Guardant Health in?
There are 12 ETFs which contain Guardant Health. All of these ETFs are listed in the table below. The ETF with the largest weighting of Guardant Health is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.